Parker Waichman LLP

FDA Now Listing Some Drugs Being Investigated

  FDA Now Listing Some Drugs. Effective immediately, the U.S. Food and Drug Administration (FDA) will begin posting a quarterly list of drugs whose safety is under investigation over complaints brought to its attention by drug companies, physicians, and patients. Although the FDA investigates drugs because of data from clinical trials and other studies, those […]

Drugs

 

FDA Now Listing Some Drugs. Effective immediately, the U.S. Food and Drug Administration (FDA) will begin posting a quarterly list of drugs whose safety is under investigation over complaints brought to its attention by drug companies, physicians, and patients. Although the FDA investigates drugs because of data from clinical trials and other studies, those drugs will not be included on the list.

FDA officials said they had not yet decided how to inform the public when an investigation clears a drug.

The quarterly list names drugs under review following reports to the AERS program; the first report appears on the FDA Website and covers January 1 to March 31.  That report list 20 drugs, four of which are being investigated for problems already announced to the public:  Heparin and anaphylaxis reactions; the diagnostic “contrast agent” Definity and cardiopulmonary reactions; Cymbalta and urinary retention; and tumor necrosis factor inhibitors and cancer in children and young adults.

Other drugs listed include Tysabri for skin melanoma and phenytoin (Dilantin) injection for its association with a disorder known as Purple Glove Syndrome.

In its quarterly listing, the FDA will name the drug and the nature of its “adverse events.”  The FDA will not describe the seriousness of the adverse event, nor will it list the number of complaints received, officials said yesterday.

drug poses a safety concern

Also, being placed on the list is not an indication that the drug is unsafe, rather the list indicates only that the FDA is looking into the drug and the possibility that the drug poses a safety concern.  The new policy is required by changes to federal law enacted last year.  FDA officials said they realize that the new policy may unintentionally alarm some patients.

Last year, the FDA’s Adverse Event Reporting System (AERS) received 482,154 unsolicited reports of potential reactions to drugs.  “The risk is that people will read more into this than what it is, which is a statement that an evaluation is underway,” said Paul Seligman of the agency’s Center for Drug Evaluation and Research. He added that he hopes patients will not stop taking a medication simply because they saw it on the list.

Another official, Gerald Dal Pan, said that the FDA’s “post-market surveillance” system is not changing, only the timing and extent to which the public is informed.  “I think the public has told us in recent years that ‘we want to know what you are working on.’  We are telling the public at pretty much the earliest stage what we are working on,” he said.

Sometimes rare side effects and interactions are not discovered until after a drug has gone to market and has been taken by many more people than those in pre-market studies.

For instance, in recent years, the painkiller Vioxx was found to increase the risk of heart attack and stroke; the diabetes drug Avandia to increase the risk of congestive heart failure; and numerous anti-epilepsy drugs to increase suicide risk.  In each of these cases, the drug’s adverse reactions were not fully discovered until well after drug approval.

Need Legal Help Regarding Drugs?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I am a client . The firm is great and very helpful. The nurse JOANNE Stevens is always helpful and concerned about her clients.
Charlene Bell
5 years ago
5 Star Reviews 150
This law firm is excellent. The staff is always accessible, concerned, caring, and knowledgeable. My law team of Julie Trinidad, Maryann Galizzi, and Nurse Joanne are consistently working to assist and support me throughout this process. Thank you all.
Mike Primo
5 years ago
5 Star Reviews 150
When I contacted Parker Waichman LLC I did not know what to expect…But I met Ms Benita Rollis and she was a Godsend ! Ms Rollis guided me through the entire process.. and whenever I had a question about anything Ms Rollis got back to me with answers immediately! I dont know what I would have done without Ms Benita Rollis .. She is the BEST ! Thank you. I have dealt with other Law Firms over the years But nobody tops Parker Waichman.
Kevin Oras
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038